These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6352046)

  • 21. Classic migraine: effective prophylaxis with metoprolol.
    Kangasniemi P; Andersen AR; Andersson PG; Gilhus NE; Hedman C; Hultgren M; Vilming S; Olesen J
    Cephalalgia; 1987 Dec; 7(4):231-8. PubMed ID: 3322569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical pharmacological aspects of dihydroergotamine timed release: activity on monoamine venospasm.
    Franchi G; Anselmi B; Del Bianco PL; Panconesi A; Sicuteri F
    Cephalalgia; 1983 Aug; 3 Suppl 1():185-8. PubMed ID: 6616602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flunarizine v. placebo in childhood migraine. A double-blind study.
    Sorge F; Marano E
    Cephalalgia; 1985 May; 5 Suppl 2():145-8. PubMed ID: 2861907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of migraine attacks: combination of dihydroergotamine tartrate and paracetamol in comparison with individual drugs and placebo].
    Hoernecke R; Doenicke A
    Med Klin (Munich); 1993 Nov; 88(11):642-8. PubMed ID: 8295604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Orally inhaled dihydroergotamine: a review.
    Tepper SJ
    Headache; 2013 Sep; 53 Suppl 2():43-53. PubMed ID: 24024602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine.
    Aurora SK; Silberstein SD; Kori SH; Tepper SJ; Borland SW; Wang M; Dodick DW
    Headache; 2011 Apr; 51(4):507-17. PubMed ID: 21457235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symptomatic and prophylactic treatment of migraine and tension-type headache.
    Schulman EA; Silberstein SD
    Neurology; 1992 Mar; 42(3 Suppl 2):16-21. PubMed ID: 1557187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Management of migraine using acupuncture in a double-blind study].
    Baust W; Stürtzbecher KH
    Med Welt; 1978 Apr; 29(16):669-73. PubMed ID: 347221
    [No Abstract]   [Full Text] [Related]  

  • 29. [Calcium carbasalate-metoclopramide combination versus dihydroergotamine in the treatment of migraine attacks].
    Pradalier A; Guérard des Lauriers A; Scheck F; Peraudeau P; Lacoste JP; Cajfinger F
    Pathol Biol (Paris); 1995 Nov; 43(9):806-13. PubMed ID: 8746103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A new therapeutic approach to menstrual migraine].
    Rozenbaum H
    Rev Fr Gynecol Obstet; 1984; 79(7-9):581-3. PubMed ID: 6528179
    [No Abstract]   [Full Text] [Related]  

  • 31. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial.
    Beisaw NE; Comerota AJ; Groth HE; Merli GJ; Weitz HH; Zimmerman RC; Diserio FJ; Sasahara AA
    J Bone Joint Surg Am; 1988 Jan; 70(1):2-10. PubMed ID: 3275673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A controlled study of dihydroergotamine in the treatment of acute migraine headache.
    Callaham M; Raskin N
    Headache; 1986 Apr; 26(4):168-71. PubMed ID: 3519528
    [No Abstract]   [Full Text] [Related]  

  • 33. Migraine prevention with timolol. A double-blind crossover study.
    Stellar S; Ahrens SP; Meibohm AR; Reines SA
    JAMA; 1984 Nov; 252(18):2576-80. PubMed ID: 6387197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine.
    Aurora SK; Rozen TD; Kori SH; Shrewsbury SB
    Headache; 2009 Jun; 49(6):826-37. PubMed ID: 19545249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abortive versus prophylactic treatment of migraine--a reappraisal.
    Mathew NT
    Headache; 1990 Mar; 30(4):238-9. PubMed ID: 2335480
    [No Abstract]   [Full Text] [Related]  

  • 36. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ergot pharmacology and alternative delivery systems for ergotamine derivatives.
    Goldstein J
    Neurology; 1992 Mar; 42(3 Suppl 2):45-6. PubMed ID: 1557192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysphonia associated with carotidynia and migraine responding to dihydroergotamine.
    White JR; Bell WL
    Headache; 2003 Jan; 43(1):69-71. PubMed ID: 12864762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DHE in the pharmacotherapy of migraine: potential for a larger role.
    Saper JR; Silberstein S; Dodick D; Rapoport A
    Headache; 2006 Nov; 46 Suppl 4():S212-20. PubMed ID: 17078853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-acting propranolol in migraine prophylaxis: results of a double-blind, placebo-controlled study.
    Pradalier A; Serratrice G; Collard M; Hirsch E; Feve J; Masson M; Masson C; Dry J; Koulikovsky G; Nguyen G
    Cephalalgia; 1989 Dec; 9(4):247-53. PubMed ID: 2692838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.